Etid klinik pou Emofili nan Washington
6 etid pou Emofili ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Washington Institute for Coagulation, Seattle
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT05568719A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Washington Center for Bleeding Disorders, Seattle
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Washington Center for Bleeding Disorders, Seattle
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Washington Institute for Coagulation d/b/a WACBD, Seattle
Ap rekriteFaz 3
Laj 1 a 74 · Gason · Mizajou Jul 1, 2026 · NCT05145127Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Washington Center for Bleeding Disorders, Seattle
Ap rekriteFaz 1
Laj 0 a 90 · Tout sèks · Mizajou Apr 3, 2026 · NCT05500807Hemophilia A Research Program
- University of Washington, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Feb 17, 2026 · NCT07414511Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.